Glen Tullman Has ‘No Interest’ In Selling Transcarent, But IPO Is a Possibility – MedCity News
After care navigation company Transcarent announced last week that it raised $126 million in Series D funding, CEO Glen Tullman told MedCity News that he has “no interest” in selling the company. However, an…
Continue Reading